# Validation of the MiCK Assay

> **NCT01770665** · — · TERMINATED · sponsor: **Pierian Biosciences** · enrollment: 21 (actual)

## Conditions studied

- Mesothelioma, Small Cell Lung Cancer, NSCLC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01770665
- **Lead sponsor:** Pierian Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2015-01
- **Final completion:** 2016-09
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Assay being revised and re-validated.
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01770665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01770665, "Validation of the MiCK Assay". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01770665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*